Cost-effective prevention of pulmonary embolus in high-risk trauma patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 42, Issue 3, 1997, Pages 456-462

  Brasel, Karen J ^a   Borgstrom, David C ^a   Weigelt, John A ^a  

^a REGIONS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; ECHOGRAPHY; HIGH RISK POPULATION; HUMAN; INFERIOR CAVA VEIN; INJURY; LUNG EMBOLISM; OUTCOMES RESEARCH; PRIORITY JOURNAL; SCREENING; TREATMENT OUTCOME; VENA CAVA FILTER;

EID: 0030946634     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199703000-00013     Document Type: Conference Paper

References (33)

1. Geerts WH, Code KI, Jay RM, et al: A prospective study of venous thromboembolism after major trauma. N Engl J Med 331:1601, 1994
2. Shackford SR, Davis JW, Hollingsworth-Fridlund P, et al: Venous thromboembolism in patients with major trauma. Am J Surg 159:365, 1990
3. Knudson MM, Collins JA, Goodman SB, et al: Thromboembolism following multiple trauma. J Trauma 32:2, 1992
4. Knudson MM, Lewis FR, Clinton A, et al: Prevention of venous thromboembolism in trauma patients. J Trauma 37:480, 1994
5. Burns GA, Cohn SM, Frumento RJ, et al: Prospective ultrasound evaluation of venous thrombosis in high-risk trauma patients. J Trauma 35:405, 1993
6. Dennis JW, Menawat S, Von Thron J, et al: Efficacy of deep venous thrombosis prophylaxis in trauma patients and identification of high-risk groups. J Trauma 35:132, 1993
7. Garlapati VS, Napolitano LM, Heard SO, et al: Asymptomatic deep venous thrombosis in the trauma patient: Is an aggressive screening protocol justified? J Trauma 39:651, 1995
8. Geerts WH, Jay RM, Code KI, et al: A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:701, 1996
9. Knudson MM, Morabito D, Paiemment GD, et al: Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma 41:446, 1996
10. Schulman S, Rhedin AS, Lindmarker P, et al: A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 332:1661, 1995
11. Hull RD, Raskob GE, Rosenbloom D, et al: Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 322:1260, 1990
12. Leach TA, Pastena JA, Swan KG, et al: Surgical prophylaxis for pulmonary embolism. Am Surg 60:292, 1994
13. Khansarinia S, Dennis JW, Veldenz HC, et al: Prophylactic Greenfield filter placement in selected high-risk trauma patients. J Vasc Surg 22:232, 1995
14. Thomas WO, Ferrara JJ, Rodning CB: A retrospective analysis of inferior vena cava filtration for prevention of pulmonary embolization. Am Surg 54:726, 1988
15. Rodriguez JL, Lopez JM, Proctor MC, et al: Early placement of prophylactic vena cava filters in injured patients at high risk for a pulmonary embolus. J Trauma 40:797, 1996
16. Alexander JJ, Yuhas JP, Piotrowski JJ: Is the increasing use of prophylactic percutaneous IVC filters justified. Am J Surg 168:102, 1994
17. Monreal M, Ruiz J, Salvador R, et al: Recurrent pulmonary embolism: A prospective study. Chest 95:976, 1989
18. Hull R, Delmore T, Genton E, et al: Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 301:855, 1979
19. Bell WR, Simon TL: Current status of pulmonary thromboembolic disease: Pathophysiology, diagnosis, prevention, and treatment. Am Heart J 103:139, 1982
20. Gallus A, Jackaman J, Tillett J, et al: Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 2:1293, 1986
21. Association of American Medical Colleges: Report on: Medical School Faculty Salaries 1994-95. Washington, DC, AAMC, 1995
22. Rogers FB, Shackford SR, Ricci MA, et al: Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism. J Am Coll Surg 180:641, 1995
23. Drummond MF, Stoddart GK, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. Oxford, Oxford University Press, 1987
24. Sox HC, Blatt MA, Higgins MC, et al: Medical Decision Making. Boston, Butterworth-Heinemann, 1988
25. Pauker SG, Kassirer JP: Decision analysis. N Engl J Med 316:250, 1987
26. Oudkerk M, van Beek EJR, van Putten WLJ, et al: Cost-effectiveness analysis of various strategies in the diagnostic management of pulmonary embolism. Arch Intern Med 153:947, 1993
27. Etchason J, Petz L, Keeler E, et al: The cost-effectiveness of preoperative autologous blood donations. N Engl J Med 332:719, 1995
28. Katz DA, Cronenwett JL: The cost-effectiveness of early surgery versus watchful waiting in the management of small abdominal aortic aneurysms. J Vasc Surg 19:980, 1994
29. Finkler SA: The distinction between cost and charges. Ann Intern Med 96:102, 1982
30. Leclerc JR, Geerts WH, Desjardins L, et al: Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med 124:619, 1996
31. Nurmohamed MT, Verhaeghe R, Haas S, et al: A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 169:567, 1995
32. Leizorovicz A, Haugh MC, Chapuis FR, et al: Low molecular weight heparin in prevention of perioperative thrombosis. Br Med J 305:913, 1992
33. Goldman L, Gordon DJ, Rifkind BM, et al: Cost and health implications of cholesterol lowering. Circulation 85:1960, 1992